News

Clinical & Regulatory,Drug Discovery & Development,Research & Development,Therapeutic Areas
Kairos reports positive interim Phase 1 safety data for ENV-105 in EGFR-mutated lung cancer
read more
Clinical & Regulatory,Drug Delivery & Formulation,Pharmaceuticals and therapeutics,Research & Development
Rani reports positive Phase 1 data for oral obesity therapy RT-114
read more
Clinical & Regulatory,Digital & Data,Genomics and sequencing,Research & Development
Seegene launches global study to evaluate comprehensive PCR testing for respiratory infections
read more
Biotech & Pharma Business,Clinical & Regulatory,Drug Discovery & Development,Pharmaceuticals and therapeutics
Adneuris licenses Phase 3 pain therapy cebranopadol to Conba for Greater China
read more
Digital & Data,Drug Discovery & Development,Research & Development
Latent Labs opens lab-validated AI drug design platform to researchers worldwide
read more
Clinical & Regulatory,Research & Development,Therapeutic Areas
PET imaging reveals widespread synaptic loss in schizophrenia
read more
Clinical & Regulatory,Medical devices,Pharmaceuticals and therapeutics,Research & Development
Revita maintains GLP-1 weight loss one year after treatment discontinuation in REMAIN-1 trial
read more
Clinical & Regulatory,Digital & Data,Research & Development,Therapeutic Areas
Two-minute digital test matches clinical benchmarks for Alzheimer’s trial screening
read more
Digital & Data,Drug Discovery & Development,Research & Development,Therapeutic Areas
Nucs AI taps Segmed’s 150 million imaging studies to strengthen oncology AI
read more
Biotech & Pharma Business,Central Nervous System
Alto Neuroscience raises $100M to expand Phase 3 treatment-resistant depression programme
read more
Clinical & Regulatory,Pharmaceuticals and therapeutics,Research & Development
EC approves first targeted first-line treatment for BRAF-mutant metastatic colorectal cancer
read more
Clinical & Regulatory,Drug Discovery & Development,Pharmaceuticals and therapeutics,Therapeutic Areas
FDA grants Fast Track status to SOTIO’s colorectal cancer ADC ahead of Phase 1/2 trial
read more
Advanced Therapies,Clinical & Regulatory,Drug Delivery & Formulation,Research & Development
EpilepsyGTx partners with ClearPoint Neuro to support Phase 1 gene therapy trial
read more
Clinical & Regulatory,Drug Discovery & Development,Pharmaceuticals and therapeutics,Research & Development,Therapeutic Areas
Skyhawk expands global Huntington’s disease trial following positive Phase 1/2 data
read more
Drug Discovery & Development,Genomics and sequencing,Research & Development
Nucleome strengthens 3D genomics platform with US patent for Micro Capture-C technology
read more
Drug Discovery & Development,Genomics and sequencing,Research & Development
Novogene expands Cambridge Omics Centre with untargeted metabolomics service
read more

Kairos reports positive interim Phase 1 safety data for ENV-105 in EGFR-mutated lung cancer

Rani reports positive Phase 1 data for oral obesity therapy RT-114

Seegene launches global study to evaluate comprehensive PCR testing for respiratory infections

Adneuris licenses Phase 3 pain therapy cebranopadol to Conba for Greater China

Latent Labs opens lab-validated AI drug design platform to researchers worldwide

PET imaging reveals widespread synaptic loss in schizophrenia

Revita maintains GLP-1 weight loss one year after treatment discontinuation in REMAIN-1 trial

Two-minute digital test matches clinical benchmarks for Alzheimer’s trial screening

Nucs AI taps Segmed’s 150 million imaging studies to strengthen oncology AI

Alto Neuroscience raises $100M to expand Phase 3 treatment-resistant depression programme

EC approves first targeted first-line treatment for BRAF-mutant metastatic colorectal cancer

FDA grants Fast Track status to SOTIO’s colorectal cancer ADC ahead of Phase 1/2 trial

EpilepsyGTx partners with ClearPoint Neuro to support Phase 1 gene therapy trial

Skyhawk expands global Huntington’s disease trial following positive Phase 1/2 data

Nucleome strengthens 3D genomics platform with US patent for Micro Capture-C technology

Novogene expands Cambridge Omics Centre with untargeted metabolomics service

main menu

recent posts

FDA grants Fast Track status to SOTIO’s colorectal cancer ADC ahead of Phase 1/2 trial

EpilepsyGTx partners with ClearPoint Neuro to support Phase 1 gene therapy trial

Skyhawk expands global Huntington’s disease trial following positive Phase 1/2 data

get connected